Comparison of 2 monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal carcinoma, thyroid carcinoma, and gliomas-Reference-Cited by-同舟云学术

Comparison of 2 monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal carcinoma, thyroid carcinoma, and gliomas

Published:2013-11 Issue:11 Volume:44 Page:2563-2570
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Routhier Caitlin Ann,Mochel Mark C.,Lynch Kerry,Dias-Santagata Dora,Louis David N.,Hoang Mai P.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference36 articles.

1. BRAF mutations in hairy-cell leukemia;Tiacci;N Engl J Med,2011

2. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytomas, ganglioglioma and extra-cerebellar pilocytic astrocytoma;Schindler;Acta Neuropathol,2011

3. Mutations of the BRAF gene in human cancer;Davies;Nature,2002

4. Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma;Long;J Clin Oncol,2011

5. BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis;Tufano;Medicine,2012

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The rapidly changing field of predictive biomarkers of non-small cell lung cancer;Pathology and Oncology Research;2024-06-17

2. Comparative efficiency of differential diagnostic methods for the identification of BRAF V600E gene mutation in papillary thyroid cancer (Review);Experimental and Therapeutic Medicine;2024-02-20

3. BRAF^V600E immunohistochemistry can reliably substitute BRAF molecular testing in the Lynch syndrome screening algorithm in colorectal cancer;Histopathology;2024-01-03

4. Characterization of Peptide Antibodies by Epitope Mapping Using Resin-Bound and Soluble Peptides;Methods in Molecular Biology;2024

5. Molecular Profiling of Syringocystadenocarcinoma Papilliferum Reveals RAS-Activating Mutations;Archives of Pathology & Laboratory Medicine;2023-04-19